SWOG clinical trial number
CTSU/A221405
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer who Desire Pregnancy
Closed
Phase
Abbreviated Title
Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Women with Endocrine Responsive BC
Activated
10/15/2015
Closed
12/31/2019
Participants
ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS LISTED ON TITLE PAGE
Research committees
Breast Cancer
Cancer Survivorship
Eligibility Criteria Expand/Collapse
Eligibility criteria are accessible from the protocol abstract page on the CTSU website (http://www.ctsu.org).
Publication Information Expand/Collapse
2025
Breastfeeding after hormone-receptor positive breast cancer: results from the POSITIVE trial
PMid: 40632989
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial (IBCSG 48-14/BIG 08-13/Alliance A221405)
PMid: PMID40743662 | PMC number: PMC12336806
2024
2023
Interrupting Endocrine Therapy to Attempt Pregnancy After Breast Cancer
PMid: PMID37133584 | PMC number: PMC10358451